| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2909366ac1f509d7fadd0859921a470a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28ada60a5f265be65a2bacca28664474
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b431067c5f5d1ce7e6c3ff9a0fb2585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d695f27654128ea4826034bffa6dbf5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ad6bc5bc0f606e3936fa563320d63f4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-50 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2010-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f177a8b36b27dc865500a6b995f77cc1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d9b01db72f8986ba87c0243aa8a86b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edccb5b332bacf68a23378400485abbd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f83c69bf6e35aa9367b322b79fbedb9 |
| publicationDate |
2011-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011045456-A2 |
| titleOfInvention |
Novel biomarkers of disease histopathology |
| abstract |
Use of the FGF‑2 and anosmin‑1 proteins for predicting the histopathology of the lesions of a patient suffering from a central nervous system (CNS) demyelinating disease by means of the detection of the amount of said proteins in a sample of isolated biological fluid. Furthermore, the present invention relates to a method for ascertaining the histopathological characteristics of the lesions of a patient suffering from a CNS demyelinating disease and to a kit for implementing said method. Preferably, the CNS demyelinating disease is multiple sclerosis and the biological fluid is cerebrospinal fluid (CSF). |
| priorityDate |
2009-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |